BusinessCannabis Science Announces the Second Frontiers Peer-Reviewed Publication of its Research Results on the Use of Cannabinoids in the Treatment of CancersBy Nasdaq OMXMay 1, 2018, 11:44 AM UTC
BusinessInspired by the Upcoming CNN Special Report, Weed: Pot Vs. Pills, by Dr. Sanjay Gupta, Cannabis Science Announces its ‘Cannabis Science to End Opioid Deaths Campaign’By Nasdaq OMXApr 27, 2018, 2:49 PM UTC
BusinessCannabis Science Issues First 2018 Guidance Report; 4/20 Court Date Set For Lawsuit Against San Joaquin County; Revenue Growth Through Acquisitions, Wholesale, and Retail Sales Channels All MultiplyBy Nasdaq OMXApr 10, 2018, 11:51 AM UTC
BusinessCrown Baus Announces Acquisition of Cannabia, the World's First Cannabis Alcoholic Beverage; Will Partner With Cannabis Science to Distribute Non-Alcoholic Versions in the United States and CanadaBy Nasdaq OMXMar 13, 2018, 4:48 PM UTC
BusinessCannabis Science Integrates iCannabinoid Into Pharmacy Openings, While Building, Product Manufacturing, Packaging & Cultivation Procedures are Pending CBIS and City ApprovalsBy Nasdaq OMXMar 5, 2018, 2:23 PM UTC
BusinessCannabis Science Groundbreaking Cancer Research Skyrockets With More Views Than 95% of All Frontiers Articles; Research Team Begins Evaluating Commercialization OptionsBy Nasdaq OMXFeb 22, 2018, 12:39 PM UTC
BusinessCannabis Science Announces an Overwhelming Response to its Groundbreaking Research on the Use of Cannabinoids in the Treatment of Cancers, Already Has More Views Than 91% of the Papers Published in all Frontiers JournalsBy Nasdaq OMXJan 18, 2018, 1:23 PM UTC
BusinessCannabis Science Announces its Construction Project Management (CPMT) Teams in Support of the Company’s Initiative to Establish Pharmacies and Medical Centers in California and Throughout the U.S.By Nasdaq OMXJan 10, 2018, 6:08 PM UTC
